{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T21:12:24Z","timestamp":1782681144127,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.jaad.2007.07.042","type":"journal-article","created":{"date-parts":[[2007,12,21]],"date-time":"2007-12-21T12:56:26Z","timestamp":1198241786000},"page":"224-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":129,"title":["Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year"],"prefix":"10.1016","volume":"58","author":[{"given":"Phoebe","family":"Rich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E.M.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank O.","family":"Nestle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Scher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chun","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Guzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2007.07.042_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0733-8635(18)30876-3","article-title":"Psoriasis of the nail","volume":"3","author":"Scher","year":"1985","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2007.07.042_bib2","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000246274","article-title":"Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients","volume":"193","author":"de Jong","year":"1996","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2007.07.042_bib3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/rheumatology\/23.4.246","article-title":"Psoriatic arthritis in psoriatic patients","volume":"23","author":"Scarpa","year":"1984","journal-title":"Br J Rheum"},{"issue":"Suppl","key":"10.1016\/j.jaad.2007.07.042_bib4","first-page":"113","article-title":"The nails in psoriatic arthritis","volume":"186","author":"Lavaroni","year":"1994","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2007.07.042_bib5","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/rheumatology\/keh198","article-title":"Extended report: nail disease in psoriatic arthritis\u2013clinically important, potentially treatable and often overlooked","volume":"43","author":"Williamson","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaad.2007.07.042_bib6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10227-002-0143-0","article-title":"Psoriatic nails: a prospective clinical study","volume":"7","author":"Salomon","year":"2003","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2007.07.042_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.07.073","article-title":"Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy","volume":"57","author":"Jiaravuthisan","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.07.042_bib8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2230.2000.00663.x","article-title":"Management of nail psoriasis","volume":"25","author":"de Berker","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2007.07.042_bib9","first-page":"174","article-title":"Nail psoriasis","volume":"50","author":"Farber","year":"1992","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2007.07.042_bib10","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(05)67566-6","article-title":"Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicenter, double-blind trial","volume":"366","author":"Reich","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2007.07.042_bib11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000250839","article-title":"Severe psoriasis: oral therapy with a new retinoid","volume":"157","author":"Fredriksson","year":"1978","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2007.07.042_bib12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1067\/S0190-9622(03)00910-1","article-title":"Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis","volume":"49","author":"Rich","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.07.042_bib13","first-page":"27","article-title":"Topical 5-fluorouracil treatment for psoriatic trachyonychia","volume":"62","author":"Schissel","year":"1998","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2007.07.042_bib14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000018281","article-title":"Dystrophic psoriatic fingernails treated with 1% 5-fluorouracil in a nail penetration-enhancing vehicle: a double-blind study","volume":"199","author":"de Jong","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2007.07.042_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000068469","article-title":"Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebo-controlled study","volume":"206","author":"Cannavo","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2007.07.042_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1346-8138.1998.tb02386.x","article-title":"Topical anthralin therapy for refractory nail psoriasis","volume":"25","author":"Yamamoto","year":"1998","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2007.07.042_bib17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1365-2133.1998.02031.x","article-title":"A simplified protocol of steroid injection for psoriatic nail dystrophy","volume":"138","author":"de Berker","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2007.07.042_bib18","first-page":"355","article-title":"Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study","volume":"68","author":"Scher","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2007.07.042_bib19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0190-9622(95)90189-2","article-title":"Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement","volume":"32","author":"Mahrle","year":"1995","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2007.07.042_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2133.2004.06070.x","article-title":"Biological therapies in the systemic management of psoriasis: International Consensus Conference","volume":"151","author":"Sterry","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2007.07.042_bib21","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jaad.2005.01.101","article-title":"Alefacept in the treatment of psoriatic nail disease: a small case series","volume":"52","author":"Cassetty","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.07.042_bib22","first-page":"339","article-title":"Alefacept in the treatment of psoriatic nail disease: a proof of concept study","volume":"5","author":"Parrish","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2007.07.042_bib23","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaad.2004.09.012","article-title":"Remission and time of resolution of nail psoriasis during infliximab therapy","volume":"52","author":"Bianchi","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.07.042_bib24","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jaad.2004.11.044","article-title":"Modification of the nail psoriasis severity index","volume":"53","author":"Parrish","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.07.042_bib25","first-page":"123","article-title":"The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis","volume":"34","author":"Cassell","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2007.07.042_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2230.2006.02305.x","article-title":"Interobserver reliability of the Nail Psoriasis Severity Index","volume":"32","author":"Aktan","year":"2006","journal-title":"Clin Exp Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962207011929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962207011929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:08:18Z","timestamp":1759270098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962207011929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0190962207011929"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2007.07.042","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2007.07.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}